-
Post-Polycythemia Vera Myelofibrosis (PPV-MF) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...
Published: June, 2022 - Pages: 382
-
Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) - Drugs In Development, 2021
Published: July, 2021 - Pages: 550
-
Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF) (Oncology) - Drugs in Development, 2021
Published: April, 2021 - Pages: 80
-
Myelofibrosis (Hematological Disorders) - Drugs in Development, 2021
Published: April, 2021 - Pages: 125
-
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2020
Published: September, 2020 - Pages: 462
-
Global Secondary Myelofibrosis Market - 2023-2030
Published: May, 2024 - Pages: 186
-
Global Chronic Idiopathic Myelofibrosis Market Research Report 2022-2032
Published: November, 2022 - Pages: 162
-
Myelofibrosis (MF) - Market Insight, Epidemiology And Market Forecast - 2032
Published: September, 2022 - Pages: 225
-
Myelofibrosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020
Published: January, 2020 - Pages: 60
-
Primary Myelofibrosis Market Insights, Epidemiology and Market Forecast- 2028
Published: April, 2019 - Pages: 120
US $
Euro €
GBP £